Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease

NCT07212088 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

BIOLOGICAL: ALC01 therapy

Sponsor

iCamuno Biotherapeutics Ltd.

Collaborators

[object Object]